Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 4, 2011


PrimeraDx said this week that Fayyaz Memon has been appointed as vice president of regulatory affairs and quality assurance.

Memon has held management positions with Thermo Fisher Scientific, Digene, Johnson & Johnson, and SmithKline Beecham, PrimeraDx said. He earned his MBA in operation and quality management and MS in mechanical engineering from Drexel University.

In July, PrimeraDx said that it would begin selling its multiplex PCR-based molecular testing technology as an open platform to laboratories wishing to develop their own molecular tests (PCR Insider, 7/14/11).

PrimeraDx is also readying its own molecular diagnostic test, a multiplex assay for Clostridium difficile, for submission to the US Food and Drug Administration.

Memon joins the company "at a key time, as we've recently launched our first product based on our unique technology for multiplex quantitative PCR, and we will be going to the FDA for clearance later this year," President and CEO Matthew McManus said in a statement.

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.